4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001493152-22-025450
Chief Business Officer bought 150 shares at $2.62 ($393)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Linscott Walt Addison Chief Business Officer | 2022-09-07 | Purchase | +150 | $2.62 | $393 | 150 | D |
| Open-market purchases · 150 sh · avg $2.62 · $393 | |||||||
Loading xslF345X03/ownership.xml…